Masimo
Open
$178.42
Prev. Close
$178.42
High
$178.43
Low
$178.41
Market Snapshot
$9.59B
-63.3
-5.71
$1.63B
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. The company is headquartered in Irvine, California and currently employs 2,200 full-time employees. The company went IPO on 2007-08-08. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The company primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
emptyResult
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. The company is headquartered in Irvine, California and currently employs 2,200 full-time employees. The company went IPO on 2007-08-08. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The company primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Recently from Cashu
Masimo Corporation Faces Legal Scrutiny Amid Danaher Acquisition Concerns
Masimo Corporation Under Legal Scrutiny Amid Acquisition by Danaher Masimo Corporation finds itself at the center of a legal investigation led by Halper Sadeh LLC, a law firm known for representing in…
Masimo Corporation Faces Legal Investigation Over Potential Shareholder Rights Violations in Acquisition Deal
Investigation Spotlight: Masimo Corporation Under Legal Scrutiny Masimo Corporation finds itself at the center of a legal investigation led by Halper Sadeh LLC, a New York-based law firm dedicated to…
Legal Scrutiny for Masimo Amid Acquisition by Danaher Raises Shareholder Concerns
Emerging Legal Concerns for Masimo Amid Acquisition Plans Masimo Corporation finds itself under scrutiny following an announcement by Halper Sadeh LLC, a prominent investor rights law firm, regarding…
Masimo Corporation Faces Scrutiny Over Governance in Danaher Acquisition Deal
Concern Over Corporate Governance: Masimo Corporation Under Scrutiny for Acquisition Deal In recent developments, Masimo Corporation finds itself at the center of a legal investigation initiated by Ha…